1. Home
  2. ARGX vs ROL Comparison

ARGX vs ROL Comparison

Compare ARGX & ROL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARGX
    SELLHOLDBUYas of 8 hours ago
  • ROL
    SELLHOLDBUYas of 8 hours ago
  • Stock Information
  • Founded
  • ARGX 2008
  • ROL 1948
  • Country
  • ARGX Netherlands
  • ROL United States
  • Employees
  • ARGX N/A
  • ROL N/A
  • Industry
  • ARGX Biotechnology: Biological Products (No Diagnostic Substances)
  • ROL Diversified Commercial Services
  • Sector
  • ARGX Health Care
  • ROL Finance
  • Exchange
  • ARGX Nasdaq
  • ROL Nasdaq
  • Market Cap
  • ARGX 37.3B
  • ROL 23.5B
  • IPO Year
  • ARGX 2017
  • ROL N/A
  • Fundamental
  • Price
  • ARGX $647.39
  • ROL $48.65
  • Analyst Decision
  • ARGX Strong Buy
  • ROL Hold
  • Analyst Count
  • ARGX 20
  • ROL 6
  • Target Price
  • ARGX $653.11
  • ROL $51.50
  • AVG Volume (30 Days)
  • ARGX 250.8K
  • ROL 1.6M
  • Earning Date
  • ARGX 02-27-2025
  • ROL 02-12-2025
  • Dividend Yield
  • ARGX N/A
  • ROL 1.35%
  • EPS Growth
  • ARGX N/A
  • ROL 16.84
  • EPS
  • ARGX N/A
  • ROL 0.97
  • Revenue
  • ARGX $1,908,659,000.00
  • ROL $3,310,625,000.00
  • Revenue This Year
  • ARGX $70.98
  • ROL $10.99
  • Revenue Next Year
  • ARGX $51.22
  • ROL $8.33
  • P/E Ratio
  • ARGX N/A
  • ROL $50.22
  • Revenue Growth
  • ARGX 85.56
  • ROL 11.07
  • 52 Week Low
  • ARGX $349.86
  • ROL $40.41
  • 52 Week High
  • ARGX $678.21
  • ROL $52.16
  • Technical
  • Relative Strength Index (RSI)
  • ARGX 56.11
  • ROL 62.65
  • Support Level
  • ARGX $639.78
  • ROL $45.77
  • Resistance Level
  • ARGX $678.21
  • ROL $46.66
  • Average True Range (ATR)
  • ARGX 15.44
  • ROL 0.72
  • MACD
  • ARGX -0.45
  • ROL 0.39
  • Stochastic Oscillator
  • ARGX 52.74
  • ROL 88.98

Stock Price Comparison Chart: ARGX vs ROL

ARGX
ROL
AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025050100150200250300350400450500550600650700ARGX VS ROL

About ARGX argenx SE

Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was initially approved in the US in December 2021 as a treatment for generalized myasthenia gravis, followed by approvals in Europe and Japan in 2022.

About ROL Rollins Inc.

Rollins is a global leader in route-based pest-control services, with operations spanning North, Central and South America, Europe, the Middle East and Africa and Australia. Its portfolio of pest-control brands includes the prominent Orkin brand, market leader in the US, where it boasts near national coverage, and in Canada. Residential pest and termite prevention dominates the services provided by Rollins, owing to the group's ongoing focus on US and Canadian markets.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use